90397151
Dec 21, 2020
Pharmaceutical preparations for neurodegenerative diseases, disorders, and conditions; pharmaceutical preparations for the treatment of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders; pharmaceutical preparations for the prevention and treatment of Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; therapeutic agents for removal of damaged mitochondrial cells for medical purposes; medical diagnostic tests, diagnostic biomarker reagents and assays for detection of Parkinson's Disease, Alzheimer's, ALS, Huntington's, diseases of aging, and other mitochondrial diseases
PharmaceuticalsPharmaceutical research and development services in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; providing medical and scientific research and information in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; medical diagnostic research and pharmaceutical development services for drug discovery in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's, Alzheimer's, ALS, Huntington's, and diseases of aging
Computer and Scientific